-
1
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-978, 1993
-
(1993)
N Engl J Med
, vol.329
, pp. 977-978
-
-
-
2
-
-
0027275397
-
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
-
Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
-
(1993)
N Engl J Med
, vol.329
, pp. 304-309
-
-
Reichard, P.1
Nilsson, B.Y.2
Rosenqvist, U.3
-
3
-
-
0021990584
-
Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes
-
Wiseman MJ, Saunders AJ, Keen H, Viberti GC: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312:617-621, 1985
-
(1985)
N Engl J Med
, vol.312
, pp. 617-621
-
-
Wiseman, M.J.1
Saunders, A.J.2
Keen, H.3
Viberti, G.C.4
-
4
-
-
0027286787
-
Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes
-
Wang PH, Lau J, Chalmers TC: Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 341:1306-1309, 1993
-
(1993)
Lancet
, vol.341
, pp. 1306-1309
-
-
Wang, P.H.1
Lau, J.2
Chalmers, T.C.3
-
5
-
-
0025602641
-
Intensive insulin therapy for treatment of type 1 diabetes
-
Hirsch IB, Farkas-Hirsch R, Skyler JS: Intensive insulin therapy for treatment of type 1 diabetes. Diabetes Care 13:1265-1283, 1990
-
(1990)
Diabetes Care
, vol.13
, pp. 1265-1283
-
-
Hirsch, I.B.1
Farkas-Hirsch, R.2
Skyler, J.S.3
-
6
-
-
0014639864
-
Absorption of injected insulin
-
Binder C: Absorption of injected insulin. Acta Pharmacol Toxicol 27 (Suppl. 2): 1-84, 1969
-
(1969)
Acta Pharmacol Toxicol
, vol.27
, Issue.SUPPL. 2
, pp. 1-84
-
-
Binder, C.1
-
7
-
-
0021264112
-
Insulin pharmacokinetics
-
Binder C, Lauritzen T, Faber O, Pramming S: Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984
-
(1984)
Diabetes Care
, vol.7
, pp. 188-199
-
-
Binder, C.1
Lauritzen, T.2
Faber, O.3
Pramming, S.4
-
9
-
-
0003058777
-
Insulin therapy
-
Alberti KGMM, Zimmet P, DeFronzo RA, Eds, Chichester, U.K., Wiley
-
Home, PD: Insulin therapy. In The International Textbook of Diabetes. 2nd ed. Alberti KGMM, Zimmet P, DeFronzo RA, Eds, Chichester, U.K., Wiley, 1996, p. 899-928
-
(1996)
The International Textbook of Diabetes. 2nd Ed.
, pp. 899-928
-
-
Home, P.D.1
-
10
-
-
77956751025
-
Insulin: The structure in the crystal and its reflection in chemistry and biology
-
Blundell T, Dodson G, Hodgkin D, Mercola D: Insulin: the structure in the crystal and its reflection in chemistry and biology. Adv Protein Chem 26:279-402, 1972
-
(1972)
Adv Protein Chem
, vol.26
, pp. 279-402
-
-
Blundell, T.1
Dodson, G.2
Hodgkin, D.3
Mercola, D.4
-
11
-
-
0023936777
-
Monomeric insulins obtained by protein engineering and their medical implications
-
Brange J, Ribel U, Hansen JF, Dodson G, Hansen MY, Havelund S, Melberg SG, Norris F, Noons K, Snel L, Sörensen AR, Voigt HO: Monomeric insulins obtained by protein engineering and their medical implications. Nature 333:679-682, 1988
-
(1988)
Nature
, vol.333
, pp. 679-682
-
-
Brange, J.1
Ribel, U.2
Hansen, J.F.3
Dodson, G.4
Hansen, M.Y.5
Havelund, S.6
Melberg, S.G.7
Norris, F.8
Noons, K.9
Snel, L.10
Sörensen, A.R.11
Voigt, H.O.12
-
12
-
-
0027097641
-
The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake
-
Drejer K: The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8:259-286, 1992
-
(1992)
Diabetes Metab Rev
, vol.8
, pp. 259-286
-
-
Drejer, K.1
-
13
-
-
0025989840
-
Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9 GluB27; AspB10; AspB28) in healthy subjects
-
Kang S, Brange J, Burch A, Volund A, Owens DR: Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9 GluB27; AspB10; AspB28) in healthy subjects. Diabetes Care 14:1057-1065, 1991
-
(1991)
Diabetes Care
, vol.14
, pp. 1057-1065
-
-
Kang, S.1
Brange, J.2
Burch, A.3
Volund, A.4
Owens, D.R.5
-
14
-
-
0025859920
-
Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9 GluB27; AspB10; AspB28) on meal related plasma glucose excursions in type 1 diabetic subjects
-
Kang S, Creagh FM, Peters JR, Brange J, Volund A, Owens DR: Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9 GluB27; AspB10; AspB28) on meal related plasma glucose excursions in type 1 diabetic subjects. Diabetes Care 14:571-577, 1991
-
(1991)
Diabetes Care
, vol.14
, pp. 571-577
-
-
Kang, S.1
Creagh, F.M.2
Peters, J.R.3
Brange, J.4
Volund, A.5
Owens, D.R.6
-
15
-
-
0027231640
-
Action profile of the rapid acting insulin analogue: Human insulin B28 Asp
-
Heinemann, L, Heise T, Jorgensen LN, Starke AAR: Action profile of the rapid acting insulin analogue: human insulin B28 Asp. Diabet Med 10:535-539, 1993
-
(1993)
Diabet Med
, vol.10
, pp. 535-539
-
-
Heinemann, L.1
Heise, T.2
Jorgensen, L.N.3
Starke, A.A.R.4
-
16
-
-
0030015569
-
Time-action profile of the insulin analogue B28Asp
-
Heinemann L, Kapitza C, Starke AAR, Heise T: Time-action profile of the insulin analogue B28Asp. Diabet Med 13:683-684, 1996
-
(1996)
Diabet Med
, vol.13
, pp. 683-684
-
-
Heinemann, L.1
Kapitza, C.2
Starke, A.A.R.3
Heise, T.4
-
17
-
-
0000246508
-
Insulin analogues and human insulin: Near-equivalent in vivo biological activity in healthy males in spite of widely different in vivo potencies
-
Kang S, Creagh FM, Ara J, Owens DR, Peters JR: Insulin analogues and human insulin: near-equivalent in vivo biological activity in healthy males in spite of widely different in vivo potencies (Abstract). Diabetes 40 (Suppl. 1):243A, 1991
-
(1991)
Diabetes
, vol.40
, Issue.SUPPL. 1
-
-
Kang, S.1
Creagh, F.M.2
Ara, J.3
Owens, D.R.4
Peters, J.R.5
-
18
-
-
0030915548
-
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment
-
Anderson JH, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 46:265-270, 1997
-
(1997)
Diabetes
, vol.46
, pp. 265-270
-
-
Anderson, J.H.1
Brunelle, R.L.2
Koivisto, V.A.3
Pfützner, A.4
Trautmann, M.E.5
Vignati, L.6
DiMarchi, R.7
-
19
-
-
0001199694
-
Timing of premeal insulins in diabetic patients on a multiple daily injection regimen: A questionnaire study
-
Jorgensen LN, Nielsen FS: Timing of premeal insulins in diabetic patients on a multiple daily injection regimen: a questionnaire study (Abstract). Diabetologia 33 (Suppl. 1): 116A, 1990
-
(1990)
Diabetologia
, vol.33
, Issue.SUPPL. 1
-
-
Jorgensen, L.N.1
Nielsen, F.S.2
-
20
-
-
0030796921
-
Are presently available insulin analogues clinically beneficial?
-
Berger M, Heinemann L: Are presently available insulin analogues clinically beneficial? Diabet Med 40 (Suppl. 2):S91-S96, 1997
-
(1997)
Diabet Med
, vol.40
, Issue.SUPPL. 2
-
-
Berger, M.1
Heinemann, L.2
-
21
-
-
0029045224
-
Do insulin treated diabetic patients use an injection-meal interval in daily life?
-
Heinemann L: Do insulin treated diabetic patients use an injection-meal interval in daily life? Diabet Med 12:449-450, 1995
-
(1995)
Diabet Med
, vol.12
, pp. 449-450
-
-
Heinemann, L.1
-
22
-
-
0027008265
-
Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal
-
Heinemann L, Starke AAR, Hohmann A, Berger M: Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Horm Metab Res 10 (Suppl. 26):137-139, 1992
-
(1992)
Horm Metab Res
, vol.10
, Issue.SUPPL. 26
, pp. 137-139
-
-
Heinemann, L.1
Starke, A.A.R.2
Hohmann, A.3
Berger, M.4
-
23
-
-
85069130331
-
Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers
-
In press
-
Home P, Barriocanal L, Lindholm A: Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers. Eur Clin Pharm. In press
-
Eur Clin Pharm.
-
-
Home, P.1
Barriocanal, L.2
Lindholm, A.3
-
24
-
-
9544243821
-
Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial blood glucose control in IDDM
-
Torlone E, Pampanelli S, Lalli C, del Sindaco P, di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli G: Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
-
(1996)
Diabetes Care
, vol.19
, pp. 945-952
-
-
Torlone, E.1
Pampanelli, S.2
Lalli, C.3
Del Sindaco, P.4
Di Vincenzo, A.5
Rambotti, A.M.6
Modarelli, F.7
Epifano, L.8
Kassi, G.9
Perriello, G.10
Brunetti, P.11
Bolli, G.12
|